Werewolf Therapeutics Inc. Gains 26.49%
Thu, Apr 28, 2022 at 05:34 PM
Werewolf Therapeutics Inc. (HOWL:NASDAQ) soared at $5.11, a gain of 26.5%. On Wed, Apr 27, 2022, HOWL:NASDAQ hit a New 2-Week Low of $4.04. The stock appeared on our News Catalysts scanner on Fri, Apr 08, 2022 at 04:39 PM in the 'AGREEMENT' category. From Thu, Apr 14, 2022, the stock recorded 25.00% Up Days and 44.44% Green Days
The stock spiked on Thu, Apr 07, 2022 at $7.55 with a volume of 12M+, and its share price has been moving sideways in recent weeks.
About Werewolf Therapeutics Inc. (HOWL:NASDAQ)
Werewolf Therapeutics Inc is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer.
Top 10 Gainers:
- Statera Biopharma Inc. (STAB:NASDAQ), 81.87%
- Swvl Holdings Corp (SWVL:NASDAQ), 50.15%
- RCM Technologies, Inc. (RCMT:NASDAQ), 44.57%
- Color Star Technology Co Ltd (CSCW:NASDAQ), 35.44%
- SQZ Biotechnologies Company (SQZ:NYSE), 34.66%
- AnPac Bio-Medical Science Co., Ltd. (ANPC:NASDAQ), 29.87%
- Werewolf Therapeutics Inc. (HOWL:NASDAQ), 26.49%
- Ra Medical Systems, Inc. (RMED:NYSE), 26.4%
- Archer Aviation Inc. Class A (ACHR:NYSE), 25.14%
- Pitney Bowes Inc. (PBI:NYSE), 23.43%